I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Cancer risk with tocilizumab/sarilumab, abatacept and ritux..:
Westermann, Rasmus
;
Cordtz, René Lindholm
;
Duch, Kirsten
...
Rheumatology. , 2024
Link:
https://doi.org/10.1093/rheumatology/keae140
RT Journal T1
Cancer risk with tocilizumab/sarilumab, abatacept and rituximab treatment in patients with rheumatoid arthritis: a Danish cohort study
UL https://suche.suub.uni-bremen.de/peid=cr-10.1093_rheumatology_keae140&Exemplar=1&LAN=DE A1 Westermann, Rasmus A1 Cordtz, René Lindholm A1 Duch, Kirsten A1 Mellemkjaer, Lene A1 Hetland, Merete Lund A1 Magnussen, Bergur A1 Dreyer, Lene PB Oxford University Press (OUP) YR 2024 SN 1462-0324 SN 1462-0332 JF Rheumatology LK http://dx.doi.org/https://doi.org/10.1093/rheumatology/keae140 DO https://doi.org/10.1093/rheumatology/keae140 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)